FDA — authorised 7 September 1982
- Marketing authorisation holder: HOSPIRA
- Status: approved
FDA authorised Amidate on 7 September 1982
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 7 September 1982.
HOSPIRA holds the US marketing authorisation.